We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Cambium (CMBM) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
Read MoreHide Full Article
Cambium (CMBM - Free Report) reported $43.05 million in revenue for the quarter ended September 2023, representing a year-over-year decline of 47%. EPS of -$0.44 for the same period compares to $0.40 a year ago.
The reported revenue represents a surprise of +0.22% over the Zacks Consensus Estimate of $42.95 million. With the consensus EPS estimate being -$0.13, the EPS surprise was -238.46%.
While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.
As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.
Here is how Cambium performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
Geographic Revenues- North America: $17.77 million versus $29.09 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a -40.9% change.
Geographic Revenues- Asia Pacific: $5.28 million versus the two-analyst average estimate of $6.13 million. The reported number represents a year-over-year change of -59.1%.
Geographic Revenues- Europe, Middle East and Africa: $14.27 million versus $12.42 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a -51.2% change.
Geographic Revenues- Caribbean and Latin America: $5.73 million versus the two-analyst average estimate of $5.77 million. The reported number represents a year-over-year change of -35.9%.
Revenues By Product Type- Point-to-Multi-Point: $23.60 million versus the seven-analyst average estimate of $25.97 million. The reported number represents a year-over-year change of -9.6%.
Revenues By Product Type- Other: $1.14 million versus $1.30 million estimated by seven analysts on average. Compared to the year-ago quarter, this number represents a -16.7% change.
Revenues By Product Type- Enterprise: $2.50 million versus $6.34 million estimated by seven analysts on average. Compared to the year-ago quarter, this number represents a -93.5% change.
Revenues By Product Type- Point-to-Point: $15.81 million versus the seven-analyst average estimate of $21.37 million. The reported number represents a year-over-year change of +2.6%.
Shares of Cambium have returned -40.5% over the past month versus the Zacks S&P 500 composite's -1.1% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Cambium (CMBM) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
Cambium (CMBM - Free Report) reported $43.05 million in revenue for the quarter ended September 2023, representing a year-over-year decline of 47%. EPS of -$0.44 for the same period compares to $0.40 a year ago.
The reported revenue represents a surprise of +0.22% over the Zacks Consensus Estimate of $42.95 million. With the consensus EPS estimate being -$0.13, the EPS surprise was -238.46%.
While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.
As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.
Here is how Cambium performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
- Geographic Revenues- North America: $17.77 million versus $29.09 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a -40.9% change.
- Geographic Revenues- Asia Pacific: $5.28 million versus the two-analyst average estimate of $6.13 million. The reported number represents a year-over-year change of -59.1%.
- Geographic Revenues- Europe, Middle East and Africa: $14.27 million versus $12.42 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a -51.2% change.
- Geographic Revenues- Caribbean and Latin America: $5.73 million versus the two-analyst average estimate of $5.77 million. The reported number represents a year-over-year change of -35.9%.
- Revenues By Product Type- Point-to-Multi-Point: $23.60 million versus the seven-analyst average estimate of $25.97 million. The reported number represents a year-over-year change of -9.6%.
- Revenues By Product Type- Other: $1.14 million versus $1.30 million estimated by seven analysts on average. Compared to the year-ago quarter, this number represents a -16.7% change.
- Revenues By Product Type- Enterprise: $2.50 million versus $6.34 million estimated by seven analysts on average. Compared to the year-ago quarter, this number represents a -93.5% change.
- Revenues By Product Type- Point-to-Point: $15.81 million versus the seven-analyst average estimate of $21.37 million. The reported number represents a year-over-year change of +2.6%.
View all Key Company Metrics for Cambium here>>>Shares of Cambium have returned -40.5% over the past month versus the Zacks S&P 500 composite's -1.1% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.